37 related articles for article (PubMed ID: 5558041)
1. Graves' disease.
Davies TF; Andersen S; Latif R; Nagayama Y; Barbesino G; Brito M; Eckstein AK; Stagnaro-Green A; Kahaly GJ
Nat Rev Dis Primers; 2020 Jul; 6(1):52. PubMed ID: 32616746
[TBL] [Abstract][Full Text] [Related]
2. The nude mouse. A possible experimental model for investigation of human thyroid tissue.
Smeds S; Anderberg B; Boeryd B; Ericson LE; Gillquist J; Persliden J
J Endocrinol Invest; 1981; 4(1):11-5. PubMed ID: 6894603
[TBL] [Abstract][Full Text] [Related]
3. The thyrotrophin receptor.
Manley SW; Knight A; Adams DD
Springer Semin Immunopathol; 1982; 5(4):413-31. PubMed ID: 6298961
[No Abstract] [Full Text] [Related]
4. Absence of allotypic variation in the autoantigen for thyroid stimulating autoantibodies.
Knight A; Adams DD
Clin Exp Immunol; 1983 May; 52(2):317-24. PubMed ID: 6134598
[TBL] [Abstract][Full Text] [Related]
5. The long-acting thyroid stimulator.
Munro DS
J R Coll Physicians Lond; 1972 Apr; 6(3):309-15. PubMed ID: 5066947
[No Abstract] [Full Text] [Related]
6. Neonatal hyperthyroidism and long-acting thyroid stimulator protector.
Nutt J; Clark F; Welch RG; Hall R
Br Med J; 1974 Dec; 4(5946):695-6. PubMed ID: 4479947
[TBL] [Abstract][Full Text] [Related]
7. Serum from patients with pernicious anaemia blocks gastrin stimulation of acid secretion by parietal cells.
de Aizpurua HJ; Ungar B; Toh BH
Clin Exp Immunol; 1985 Aug; 61(2):315-22. PubMed ID: 4042425
[TBL] [Abstract][Full Text] [Related]
8. Detection of thyroid-stimulating antibodies in thyroid diseases, employing rat thyroid fragment perifusion.
Attali JR; Valensi P; Darnis D; Weisselberg C; Sebaoun J
J Endocrinol Invest; 1987 Apr; 10(2):171-7. PubMed ID: 2884248
[TBL] [Abstract][Full Text] [Related]
9. Progress in endocrine exophthalmos.
Havard CW
Br Med J; 1979 Apr; 1(6169):1001-4. PubMed ID: 582020
[No Abstract] [Full Text] [Related]
10. Iodinating activity of thyroid tissue in toxic diffuse goiter.
Nagataki S; Uchimura H; Ikeda H; Kuzuya N; Masuyama Y
J Clin Invest; 1977 Apr; 59(4):723-9. PubMed ID: 576614
[TBL] [Abstract][Full Text] [Related]
11. Peripheral blood B-lymphocyte abnormalities associated with hyperthyroidism of Graves' disease.
Hsu CC; Chen Y; Patterson R
Clin Exp Immunol; 1976 Dec; 26(3):431-40. PubMed ID: 64326
[TBL] [Abstract][Full Text] [Related]
12. Changes in LATS and other thyoid autoantibody levels with therapy.
Kilpatrick JA
N Z Med J; 1974 Dec; 80(529):495-6. PubMed ID: 4532201
[No Abstract] [Full Text] [Related]
13. LATS protector, the human thyroid stimulator.
Adams DD
N Z Med J; 1975 Jan; 81(531):22-3. PubMed ID: 1055310
[No Abstract] [Full Text] [Related]
14. Correlation between long-acting thyroid stimulator protector level and thyroid 131-I uptake in thyrotoxicosis.
Adams DD; Kennedy TH; Stewart RD
Br Med J; 1974 Apr; 2(5912):199-201. PubMed ID: 4406686
[TBL] [Abstract][Full Text] [Related]
15. [Thyroid-stimulating antibodies].
Kandror VI; Ibragim MD
Probl Endokrinol (Mosk); 1985; 31(4):75-80. PubMed ID: 2864686
[No Abstract] [Full Text] [Related]
16. The long-acting thyroid stimulator.
Munro DS
Sci Basis Med Annu Rev; 1970; ():21-30. PubMed ID: 4920180
[No Abstract] [Full Text] [Related]
17. Evidence to suggest that LATS protector stimulates the human thyroid gland.
Adams DD; Kennedy TH
J Clin Endocrinol Metab; 1971 Jul; 33(1):47-51. PubMed ID: 5558041
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
